Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly

Table 2

Proportions of metabolic diseases in acromegaly patients.

Metabolic diseases	Acromegaly	Controls
	N/total (%)	N/total (%)
Glucose metabolism
Diabetes (DM)	19/66 (28.8)	7/66 (10.6)	0.009
Impaired glucose tolerance (IGT)	17/66 (25.8)	24/66 (36.4)	0.188
Normal	30/66 (45.5)	35/66 (53.0)	0.384
BMI
Obesity	19/66 (28.8)	36/121 (29.8)	0.890
Overweight	27/66 (40.9)	53/121 (43.8)	0.702
Normal	20/66 (30.3)	32/121 (26.4)	0.574
Hypertension	17/68 (25.0)	29/121 (24.0)	0.874
Hyperlipidemia	20/38 (52.6)	58/120 (48.3)	0.644